← ANALYST RATINGS · TIPRANKS
Fortrea Holdings Inc. (FTRE): analyst forecast and price target
Analyst consensus
Moderate Buy5 Buy3 Hold0 Sell
Ratings of 8 analysts in the last 3 months · top analysts only12-month forecast
Based on 8 price targets given in the last 3 months, the average target is $22.43, the highest $25.00, the lowest $19.00. The average is −0.3% from the last price of $22.49.
Analyst ratings 11
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| AI OpenAI BiotechnologyOpenAI 5.2 | TipRanks - OpenAI | $24.00 → $23.50−2.1% | Hold | +4.5% | Reiterated | 17.10.26on TipRanks 15:05 | — | |
| AI PerPlexity BiotechnologyPerPlexity SonarPro | TipRanks - PerPlexity | $23.50 → $23.00−2.1% | Hold | +2.3% | Reiterated | 17.10.26on TipRanks 15:05 | — | |
| AI xAi BiotechnologyxAI Grok-4 | TipRanks - xAI | $20.50 → $23.50+14.6% | Hold | +4.5% | Reiterated | 16.10.26on TipRanks 10:05 | — | |
| AI DeepSeek BiotechnologyDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $20.50 → $23.50+14.6% | Hold | +4.5% | Reiterated | 16.10.26on TipRanks 10:05 | — | |
| AI Anthropic BiotechnologyAnthropic Opus-4.6 | TipRanks - Anthropic | $19.50 → $22.50+15.4% | Hold | 0.0% | Reiterated | 16.10.26on TipRanks 10:05 | — | |
| AI Google BiotechnologyGemini 3.1Pro | TipRanks - Google | $21.50 → $24.50+14.0% | Hold | +8.9% | Reiterated | 16.10.26on TipRanks 10:05 | — | |
| Justin Bowers★★★★★★★★★★#8679 · hits 47% · avg 0.0% | Deutsche Bank | $20.00 → $25.00+25.0% | Buy | +11.2% | Upgrade | 15.10.26on TipRanks 06:00 | +6.3%next day 0.0% | ↗ |
| Michael Ryskin★★★★★★★★★★#1994 · hits 58% · avg +5.1% | Bank of America Securities | $13.00 → $15.50+19.2% | Sell | −31.1% | Reiterated | 09.10.26on TipRanks 08:10 | +1.7%next day +0.8% · 5 days +9.9% | ↗ |
| Luke Sergott★★★★★★★★★★#1255 · hits 49% · avg +9.8% | Barclays | $22.00 → $23.00+4.5% | Buy | +2.3% | Upgrade | 06.10.26on TipRanks 06:15 | −2.1%next day −0.8% · 5 days +0.8% | ↗ |
| Kevin Caliendo★★★★★★★★★★#2646 · hits 56% · avg +5.6% | UBS | $22.00 | Hold | −2.2% | Initiated | 30.09.26on TipRanks 05:35 | +1.3%next day −2.9% · 5 days +1.1% | ↗ |
| Jared Haase★★★★★★★★★★#1700 · hits 89% · avg +24.8% | William Blair | — | Hold | — | Reiterated | 10.09.26on TipRanks 10:10 | +2.0%next day +0.2% · 5 days +18.5% | ↗ |
| Jailendra Singh★★★★★★★★★★#12131 · hits 43% · avg −6.4% | Truist Financial | — | Buy | — | Reiterated | 03.09.26on TipRanks 08:15 | +0.4%next day −4.6% · 5 days −6.5% | ↗ |
| Charles Rhyee★★★★★★★★★★#1937 · hits 54% · avg +5.6% | TD Cowen | $19.00 → $23.00+21.1% | Buy | +2.3% | Reiterated | 04.08.26on TipRanks Aug 3 20:50 | −6.8%next day +6.1% · 5 days +8.6% | ↗ |
| Ann Hynes★★★★★★★★★★#1003 · hits 59% · avg +8.1% | Mizuho Securities | $16.00 → $19.00+18.8% | Hold | −15.5% | Reiterated | 31.07.26on TipRanks Aug 4 08:18 | −0.2%next day −2.6% · 5 days −7.4% | ↗ |
| Patrick B Donnelly★★★★★★★★★★#2106 · hits 54% · avg +6.0% | Citi | $20.00 → $22.00+10.0% | Buy | −2.2% | Reiterated | 31.07.26on TipRanks 06:52 | −0.2%next day −2.6% · 5 days −7.4% | ↗ |
| Eric Coldwell★★★★★★★★★★#1091 · hits 59% · avg +7.7% | Robert W. Baird | $21.00 → $23.00+9.5% | Buy | +2.3% | Reiterated | 30.07.26on TipRanks 08:03 | −8.1%next day −0.2% · 5 days −10.9% | ↗ |
| Elizabeth Anderson CFA★★★★★★★★★★#2664 · hits 55% · avg +4.4% | Evercore ISI | $20.00 → $25.00+25.0% | Buy | +11.2% | Reiterated | 30.07.26on TipRanks Jul 29 13:08 | +0.1%next day −8.1% · 5 days −12.1% | ↗ |
| No ratings for this filter. | ||||||||
The latest rating of each analyst in the last 12 months, as TipRanks lists them. Every rating kept, earlier ones included
Best analysts covering Fortrea Holdings Inc.
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $22.00 at a price of $19.95 (+10.3%); now: $21.94 at $22.49 (−2.4%).
PriceAverage targetTop analysts’ target
Recommendation trend · top analysts
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 0 | 0 | 0 | 0 | 0 |
| Buy | 6 | 6 | 8 | 4 | 4 | 2 |
| Hold | 6 | 6 | 8 | 5 | 7 | 4 |
| Sell | 1 | 1 | 2 | 1 | 1 | 0 |
Earnings and sales forecast
Next report: 29.10.26 (Q3 2026, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $0.22 (from $0.16 to $0.28). Last quarter: $0.23.
Sales
Next quarter’s sales estimate — $672M (from $667M to $680M). Last quarter: $678M.
Best top-analyst consensus in the sector · Healthcare
About Fortrea Holdings Inc.
- CEO: Anshul Thakral
- Employees: 14,000
- 8 Moore Drive, Durham, NC, 27713, US
- www.fortrea.com
Fortrea Holdings Inc. functions as a global contract research organization (CRO), concentrating on providing development services for biopharmaceutical products and medical devices. The company's operations are divided into two main segments: Clinical Services and Enabling Services. Its Clinical Services division offers support across the entire spectrum of clinical pharmacology and development. The Enabling Services segment, conversely, delivers patient access programs and cutting-edge clinical trial technology solutions, aiming to simplify complex randomization processes and optimize the supply of trial medications for its customers. Fortrea presents a range of engagement options, such as full-service provision, functional service provider (FSP) models, and hybrid structures. Additionally, its portfolio includes managing clinical trials from Phase I through IV, offering distinctive technology-powered trial solutions, and providing post-market approval services. The company's client base primarily consists of pharmaceutical, biotechnology, and medical device entities. Fortrea Holdings Inc. was founded in 2023 and has its headquarters in Durham, North Carolina.
Data from the stock’s TipRanks forecast page, read 18 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗